What's new? Log in Free sign up

iSpecimen (ISPC)

Company Profile

Company profile

Ticker

ISPC

Exchange

Incorporated

Location

Fiscal year end

Sector

Professional, Scientific, and Technical Services > Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Industry (SIC)

Services - Commercial Physical & Biological Research

PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Medpace • Zymergen • Incyte • SomaLogic ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Material Contracts & Credit Agreements

IRS number

270480143

ISPC stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

Previously Appointed Interim CEO in September 2022

Prospectus supplement

Departure of Directors or Certain Officers

Results of Operations and Financial Condition

Quarterly report

8 Nov 22

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers

Notice of effectiveness

Prospectus supplement

Results of Operations and Financial Condition

Transcripts

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Christopher Ianelli

Steven R. Ph.D. Gullans

Joseph J. Basile

George H. Scholl

Empery Asset Management, LP

Financial summary

Financial statements Chart ISPC financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	20.66 mm	20.66 mm	20.66 mm	20.66 mm	20.66 mm	20.66 mm
Cash burn (monthly)	1.01 mm	(no burn)	1.03 mm	836.62 k	(no burn)	112.92 k
Cash used (since last report)	4.17 mm	n/a	4.26 mm	3.45 mm	n/a	465.68 k
Cash remaining	16.49 mm	n/a	16.39 mm	17.21 mm	n/a	20.19 mm
Runway (months of cash)	16.3	n/a	15.9	20.6	n/a	178.8

Beta Read what these cash burn values mean

Financial data from iSpecimen earnings reports.

Institutional ownership, Q3 2022

ISPC institutional ownership history Ownership history

5.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	15	14	+7.1%
Opened positions	2	3	-33.3%
Closed positions	1	2	-50.0%
Increased positions	6	6	–
Reduced positions	3	2	+50.0%

13F shares	Current	Prev Q	Change
Total value	781.00 k	813.00 k	-3.9%
Total shares	473.07 k	372.83 k	+26.9%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Vanguard	163.70 k	$270.00 k	+166.3%
Bleichroeder	65.83 k	$109.00 k	0.0%
Grimes & Company	65.59 k	$108.00 k	+5.8%
BLK Blackrock	56.70 k	$94.00 k	0.0%
TETAA Teton Advisors	40.00 k	$66.00 k	0.0%
Geode Capital Management	21.60 k	$35.00 k	-7.5%
Schonfeld Strategic Advisors	20.60 k	$34.00 k	+4.0%
Virtu Financial	10.68 k	$18.00 k	NEW
Main Street Financial Solutions	10.50 k	$17.00 k	0.0%
MS Morgan Stanley	8.00 k	$13.00 k	+60.0%

Largest transactions	Shares	Bought/sold	Change
Vanguard	163.70 k	+102.24 k	+166.3%
Citadel Advisors	0.00	-19.80 k	EXIT
Virtu Financial	10.68 k	+10.68 k	NEW
Grimes & Company	65.59 k	+3.58 k	+5.8%
MS Morgan Stanley	8.00 k	+3.00 k	+60.0%
UBS UBS Group AG - Registered Shares	5.28 k	+2.93 k	+124.5%
Geode Capital Management	21.60 k	-1.74 k	-7.5%
Tower Research Capital	3.60 k	-1.36 k	-27.3%
Schonfeld Strategic Advisors	20.60 k	+800.00	+4.0%
BAC Bank Of America	919.00	-134.00	-12.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ISPC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 Jan 23	Jill Mullan	Common Stock	Option exercise	Acquire M	No	No	1	66,637	66.64 k	246,226
17 Jan 23	Jill Mullan	Option Common Stock	Option exercise	Dispose M	No	No	1	66,637	66.64 k	10,000
3 Jan 23	Andrew L. Ross	Option Common Stock	Grant	Acquire A	No	No	1.41	10,000	14.10 k	23,525
3 Jan 23	Joseph J. Basile	Option Common Stock	Grant	Acquire A	No	No	1.41	10,000	14.10 k	11,668
3 Jan 23	John L Brooks	Option Common Stock	Grant	Acquire A	No	No	1.41	10,000	14.10 k	23,525
3 Jan 23	George H. Scholl	Option Common Stock	Grant	Acquire A	No	No	1.41	10,000	14.10 k	23,525

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

iSpecimen Names Tracy Curley As Chief Executive Officer Effective Immediately

iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare

Stocks That Hit 52-Week Lows On Wednesday

Wednesday saw 219 companies set new 52-week lows.

iSpecimen Q3 EPS $(0.35) Misses $(0.34) Estimate, Sales $2.58M Beat $2.45M Estimate

iSpecimen (NASDAQ:ISPC) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 59.09 percent decrease over losses of $(0.22) per share from the

Earnings Scheduled For November 8, 2022

Press releases

From Benzinga Pro

Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders,

iSpecimen Appoints Eric Langlois as Chief Revenue Officer

LEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a

iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023

iSpecimen Names Tracy Curley as Chief Executive Officer